IRON

Disc Medicine (IRON)

Disc Medicine Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/02/14	21 : 50	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:IRON	Disc Medicine Inc
2025/02/13	08 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2025/02/13	08 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2025/02/12	23 : 08	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:IRON	Disc Medicine Inc
2025/02/05	07 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2025/01/25	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2025/01/24	07 : 24	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IRON	Disc Medicine Inc
2025/01/23	11 : 35	GlobeNewswire Inc.	Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:IRON	Disc Medicine Inc
2025/01/22	07 : 24	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IRON	Disc Medicine Inc
2025/01/22	06 : 01	GlobeNewswire Inc.	Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:IRON	Disc Medicine Inc
2025/01/21	21 : 52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2025/01/21	21 : 45	GlobeNewswire Inc.	Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission	NASDAQ:IRON	Disc Medicine Inc
2025/01/21	09 : 00	GlobeNewswire Inc.	Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)	NASDAQ:IRON	Disc Medicine Inc
2025/01/18	06 : 00	GlobeNewswire Inc.	Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:IRON	Disc Medicine Inc
2025/01/10	23 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2025/01/10	23 : 00	GlobeNewswire Inc.	Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025	NASDAQ:IRON	Disc Medicine Inc
2025/01/07	07 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2025/01/03	06 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/12/10	02 : 00	GlobeNewswire Inc.	Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
2024/12/09	22 : 48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/12/09	10 : 00	GlobeNewswire Inc.	Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
2024/11/27	10 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/11/26	06 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/11/20	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IRON	Disc Medicine Inc
2024/11/20	08 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
2024/11/16	06 : 47	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IRON	Disc Medicine Inc
2024/11/16	06 : 43	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:IRON	Disc Medicine Inc
2024/11/16	06 : 39	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
2024/11/16	06 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
2024/11/15	07 : 44	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:IRON	Disc Medicine Inc